Navigation Links
Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
Date:9/1/2009

Astra Zeneca, Alex was SVP Drug Discovery at CAT, where he built a recognised world class antibody discovery capability. In addition to playing a major role in the creation of the CAT-AZ alliance, he led CAT discovery collaborations with Wyeth, Merck, Human Genome Sciences, Elan, Pfizer, Immunex and others. Alex gained his PhD in Dr Sir Greg Winter's laboratory at the MRC Laboratory of Molecular Biology, University of Cambridge and held post-doctoral positions at the University of California San Diego.

Commenting on these management changes, Dr Keith McCullagh, Affitech's Chairman, said: "I am delighted to welcome Robert Burns and Alex Duncan to Affitech. They bring exceptional experience in structuring biotech alliances and the discovery and development of competitive human antibody medicines. I am confident that under their business and scientific leadership the recently listed Affitech will emerge as an exciting new international competitor in the rapidly growing pharmaceutical sector of human antibody medicines."

"I would also like to thank Dr Achim Kaufhold for his dedication and commitment to the success of Affitech over the last year and wish him every success as he returns to Switzerland to pursue other opportunities.

Dr Robert Burns, Affitech's new CEO, commented: "Alex and I are both excited to be joining the Affitech team at this transformational point. The Company has developed powerful antibody selection technology that has already shown success in generating potential human antibody drugs against previously challenging new disease targets. I think Affitech has a strong competitive advantage in the antibody field and I look forward to building the business into an internationally successful biopharmaceutical company."

The management changes announced today take place with immediate effect.

About Affitech

Affitech A/S is a human
'/>"/>

SOURCE Affitech AS
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
2. Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company
3. Affitech Acquires Pharmexas Diabody Technology
4. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
5. Affitech Appoints Dr. Keith McCullagh as Chairman
6. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
7. ERT Appoints New Associate Director of Business Development - Japan
8. NeurogesX Appoints New Board Director and Audit Committee Chairman
9. Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer
10. Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors
11. Nucleix Appoints Meirav Chovav Vice President of Strategic Affairs and to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Xencor, Inc. ... company developing engineered monoclonal antibodies for the treatment ... cancer, today announced the appointment of Debra ... and the appointment of Lloyd Rowland , ... counsel. "Debra,s expertise in biologics ...
(Date:9/2/2014)... , Sept. 2, 2014  Synthetic Biologics, Inc. ... biologic and drug candidates targeting specific pathogens that ... results from its final preclinical toxicology study of ... guidance, this bridging study was required to move ... to prevent the devastating effects of Clostridium ...
(Date:9/2/2014)... NC (PRWEB) September 02, 2014 ... of its 11th clinical research site: PMG Research of ... ownership and operation of the clinical research department at ... expanding PMG’s presence in eastern North Carolina. This new ... For the patients in Rocky Mount and the surrounding ...
(Date:9/2/2014)... CAMBRIDGE, Massachusetts , September 2, 2014 ... experience to BioData,s research and lab management services  ... lab management service, is pleased to announce the appointment ... CEO. Culot most recently served as VP Marketing and ... for life science research and clinical applications. ...
Breaking Biology Technology:Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5PMG Research Announces the Formation of its Eleventh Site 2PMG Research Announces the Formation of its Eleventh Site 3Louis Culot Appointed as BioData's CEO 2
... Dr. ... San Antonio and South Central Texas, , ... (PRWEB) June 15, 2010 -- For those looking for a trimmer physique without ... Zeltiq ™ Procedure, a new non-invasive body contouring procedure, at his practice - Advanced ...
... data from a retrospective cohort study showed that up to three quarters ... have a substantial adverse effect on major PD-related clinical and health economic ... Disease and Movement Disorders in Buenos Aires, Argentina ( June ... , "The ...
... leading publication on diversity and business, has recognized University Hospitals as a leader among ... , , ... Companies for Diversity based on results from an extensive questionnaire. This is the first ... , , ...
Cached Biology Technology:Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction 2Dr. Suresh Koneru Introduces Zeltiq Non-Invasive Procedure For Fat Reduction 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 2New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 3New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinson's Disease 4Diversity Publication Names University Hospitals One of Top Hospital Systems in the Nation 2
(Date:9/2/2014)... perching birds, that migrate by night tend to fly ... reach their destinations. This seasonal difference in flight speed ... migratory flights, says researcher Cecilia Nilsson of Lund University ... Sociobiology . , Nilsson, in a group led ... measure over three years the speed by which birds ...
(Date:9/2/2014)... 2, 2014 Best-selling author Sam Kean stops by ... Megalodon, the 50-foot super shark that, despite what "Shark ... Learn all about it at http://youtu.be/KhFygIoW_MA . , ... of Madness, Love and the History of the World ... the Reactions treatment in a 10-episode video series produced ...
(Date:9/2/2014)... lithographic limestone is well known as a result ... area (for example, Archaeopteryx). Now, for the first ... French equivalent of these outcrops - discoveries which ... water treader. , Despite the abundance of fossils ... been obtained from the Late Kimmeridgian equivalents of ...
Breaking Biology News(10 mins):Migrating birds sprint in spring, but take things easy in autumn 2Exceptionally well preserved insect fossils from the Rhône Valley 2
... Research to be presented at the Annual Meeting of the ... society for research into all aspects of eating and drinking ... their pregnancy were at risk to develop obesity and type ... that both prenatal stress exposure and passive stress coping style ...
... make a person more susceptible to the lung infection ... , the online open-access journal of the American Society ... (METH) significantly enhanced colonization of the lungs by ... and the time to death in mouse models. ...
... mind that is, your happiness affects your genes, ... from UCLA,s Cousins Center for Psychoneuroimmunology and the University of ... What they found is that different types ... People who have high levels of what ...
Cached Biology News:Methamphetamine increases susceptibility to deadly fungal infection 2Methamphetamine increases susceptibility to deadly fungal infection 3Be happy: Your genes may thank you for it 2Be happy: Your genes may thank you for it 3
Goat polyclonal to Factor VIII, prediluted ( Abpromise for all tested applications). Antigen: Full length native protein (purified) (Human): Factor VIII from blood. Entrez GeneID: 2157 Sw...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: